Literature DB >> 27515981

[Mucosal manifestations of epidermolysis bullosa : Clinical presentation and management].

C Prodinger1, A Diem2, J W Bauer2, M Laimer2.   

Abstract

Mucosal lesions occur with different prevalence and severity in all subtypes of hereditary epidermolysis bullosa (EB), a group of rare genodermatoses. They are associated with increased morbidity and mortality, especially in severe junctional and dystrophic subtypes. Despite progress in clinical approaches to curative therapy, the management of these patients is still primarily symptom-oriented. Current recommendations mainly rely on expert opinion and experience from health care professionals of specialized centers, since the rarity of this disease largely limits the availability and feasibility of randomized controlled trials. Accurate preventive and supportive care measures, however, can significantly lessen symptoms, avoid/ameliorate complications, and enhance the quality of life of these patients.

Entities:  

Keywords:  Genodermatoses; Multisystemic disease; Prevention; Quality of life; Wound care

Mesh:

Substances:

Year:  2016        PMID: 27515981     DOI: 10.1007/s00105-016-3854-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  37 in total

Review 1.  Nutritional support for children with epidermolysis bullosa.

Authors:  Lesley Haynes
Journal:  Br J Nurs       Date:  2006 Nov 9-22

2.  Esophageal strictures in children with recessive dystrophic epidermolysis bullosa: an 11-year experience with fluoroscopically guided balloon dilatation.

Authors:  Richard G Azizkhan; Wolfgang Stehr; Aliza P Cohen; Eric Wittkugel; Michael K Farrell; Anne W Lucky; Benjamin D Hammelman; Neil D Johnson; John M Racadio
Journal:  J Pediatr Surg       Date:  2006-01       Impact factor: 2.545

Review 3.  The protective and therapeutic mechanisms of sucralfate.

Authors:  D Hollander; A Tarnawski
Journal:  Scand J Gastroenterol Suppl       Date:  1990

4.  The challenges of meeting nutritional requirements in children and adults with epidermolysis bullosa: proceedings of a multidisciplinary team study day.

Authors:  L Hubbard; L Haynes; M Sklar; A E Martinez; J E Mellerio
Journal:  Clin Exp Dermatol       Date:  2011-06-14       Impact factor: 3.470

5.  Innovations in chronic anal fissure treatment: A systematic review.

Authors:  Aaron Poh; Kok-Yang Tan; Francis Seow-Choen
Journal:  World J Gastrointest Surg       Date:  2010-07-27

6.  Topical application of mitomycin-C in oesophageal strictures.

Authors:  S Rosseneu; N Afzal; B Yerushalmi; E Ibarguen-Secchia; P Lewindon; D Cameron; T Mahler; K Schwagten; H Köhler; K J Lindley; M Thomson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-03       Impact factor: 2.839

7.  Tracheolaryngeal complications of inherited epidermolysis bullosa: cumulative experience of the national epidermolysis bullosa registry.

Authors:  Jo-David Fine; Lorraine B Johnson; Madeline Weiner; Chirayath Suchindran
Journal:  Laryngoscope       Date:  2007-09       Impact factor: 3.325

Review 8.  Inherited epidermolysis bullosa.

Authors:  Jo-David Fine
Journal:  Orphanet J Rare Dis       Date:  2010-05-28       Impact factor: 4.123

9.  The clinical effectiveness of Movicol in children with severe constipation: an outcome audit.

Authors:  Sandra Hanson; Nav Bansal
Journal:  Paediatr Nurs       Date:  2006-03

10.  Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the National Epidermolysis Bullosa Registry.

Authors:  Jo-David Fine; Lorraine B Johnson; Madeline Weiner; Chirayath Suchindran
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-02       Impact factor: 2.839

View more
  1 in total

1.  Anesthetic Challenges of an Adolescent Patient with Epidermolysis Bullosa and Gitelman's Syndrome Undergoing Posterior Spinal Fusion Surgery.

Authors:  Edgar E Kiss; Neethu Chandran; Gijo Alex; Patrick Olomu
Journal:  J Pediatr Genet       Date:  2020-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.